Effect of intracerebroventricular injection of atropine on metabolic responses during exercise in untrained rats.
To investigate the role of the central cholinergic system in the regulation of metabolism during exercise, we injected atropine (5 x 10(-7) mol) into the lateral cerebral ventricle of normal and adrenodemedullated (ADM) untrained rats submitted to exercise on a treadmill (15 m min(-1), 5% grade) until exhaustion. Concentrations of blood glucose, plasma free fatty acids (FFA), and lactate were measured before and every 10 min after the start of exercise for a period of 60 min. Adrenomedullectomy had no effect on the maximal capacity of exercise (MCE), but atropine administered intracerebroventricularly (i.c.v.) reduced the maximal capacity of exercise of both normal and ADM rats. In normal rats, blood concentrations of glucose and plasma free fatty acids remained essentially unchanged compared to the levels at rest, whereas in ADM rats a rapid increase in plasma glucose and plasma free fatty acids levels occurred during exercise. These data indicate that adrenomedullectomy disrupted the accuracy of the feedback mechanism that regulates the mobilization of extramuscular fuels during exercise in normal rats. In addition, ADM rats showed an increased lipid mobilization as a source of energy during exercise, which might explain the increased plasma glucose by an inhibition of muscle glucose uptake. These results suggest that central cholinergic neurons might be involved in the control of energy substrate adjustment during exercise, thereby reducing the maximal capacity of exercise. In addition, the results of this study suggest that the adrenal glands are important for an accurate feedback mechanism during exercise.
Lima
N R
NR
Laboratory of Physiology of Exercise, School of Physical Education, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Coimbra
C C
CC
Marubayashi
U
U
D000313:Adrenal Medulla / Q000502:physiology* / Q000601:surgery; D000315:Adrenalectomy; D000704:Analysis of Variance; D000818:Animals; D001285:Atropine / Q000008:administration & dosage*; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005246:Feedback / Q000187:drug effects / Q000502:physiology; D007276:Injections, Intraventricular; D019344:Lactic Acid / Q000097:blood*; D008053:Lipid Mobilization / Q000502:physiology; D008297:Male; D010805:Physical Conditioning, Animal / Q000502:physiology*; D051381:Rats; D012016:Reference Values
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D019344:Lactic Acid; D001285:Atropine